Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of Protective Antibody Production After COVID-19 Vaccination Among Patients Under Hemodialysis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04871945
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:45.410613+00:00
Published At
2022-03-17T00:00:00+00:00
Record Updated At
2022-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Covid19", "Vaccine Reaction", "Hemolysis", "End-stage Renal Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-17"
protocolSection.identificationModule.nctId
"NCT04871945"
protocolSection.identificationModule.officialTitle
"Evaluation of Protective Antibody Production After COVID-19 Vaccination Among Patients Under Hemodialysis"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Covid19 (protocolSection.conditionsModule.conditions)
  • Vaccine Reaction (protocolSection.conditionsModule.conditions)
  • Hemolysis (protocolSection.conditionsModule.conditions)
  • End-stage Renal Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.